Women with a BRCA1/2 mutation are less likely to get ovarian cancer. Ameta-analysis10 research on women with BRCA mutation showed that the risk of ovarian cancer is reduced by 80% after salpingo-oophorectomy. Salpingo-oophorectomy reduces the risk of breast cancer by 50%. A woman with a BRCA1/2 mutation should undergo this operation, especially after the desire to have a child is no longer existent. Blood test for CA 125 protein (cancer antigen) should be continued after surgery.